Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
溶瘤性H-1细小病毒在首个I/IIa期胶质母细胞瘤试验中显示出安全性和免疫原性活性
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2017.08.016
Geletneky, Karsten; Hajda, Jacek; Angelova, Assia L; Leuchs, Barbara; Capper, David; Bartsch, Andreas J; Neumann, Jan-Oliver; Schöning, Tilman; Hüsing, Johannes; Beelte, Birgit; Kiprianova, Irina; Roscher, Mandy; Bhat, Rauf; von Deimling, Andreas; Brück, Wolfgang; Just, Alexandra; Frehtman, Veronika; Löbhard, Stephanie; Terletskaia-Ladwig, Elena; Fry, Jeremy; Jochims, Karin; Daniel, Volker; Krebs, Ottheinz; Dahm, Michael; Huber, Bernard; Unterberg, Andreas; Rommelaere, Jean
